Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID
· Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT
Ovid Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 28.41M | 21.14M | 26.3M | 15.02M | 29.69M | 30.77M | 27.04M | 57.44M | 71.62M | 63.05M | 129M | 58.26M | 72.81M | 166.67M | 187.8M | 201.78M | 212.17M | 233.05M |
Short-Term Investments | 9.93M | 21.86M | 26.77M | 47.7M | 47.28M | 59.49M | 78.79M | 29.64M | 24.89M | 54.67M | 84.13M | 79.6M | 79.55M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 20.91M | 20.91M | 20.97M | 21.13M | 21.05M | 23.95M | 19.56M | 16.12M | 16.47M | 5.98M | 5.62M | 5.95M | 2.23M | 2.78M | 1.63M | 1.63M | 1.61M | n/a |
Other Long-Term Assets | 1.93M | 1.93M | 1.93M | 1.96M | 1.96M | 28K | 26.6K | 1.96M | 1.96M | 1.96M | 1.97M | 1.97M | 2.01M | 2.03M | 1.93M | 147.00 | 404.73K | 402.68K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | n/a | n/a | n/a | 1.02M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.00 |
Other Current Assets | 3.74M | 2.92M | 2.87M | 3.12M | 3.92M | 2.91M | 3.76M | 4.64M | 5.65M | 1.8M | 2.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 42.09M | 45.92M | 55.94M | 65.83M | 80.89M | 93.17M | 109.6M | 91.71M | 102.17M | 119.52M | 131.38M | 140.5M | 156.08M | 170.09M | 190.48M | 205.06M | 215.87M | 236.66M |
Property-Plant & Equipment | 12.5M | 12.86M | 13.23M | 13.59M | 13.97M | 14.31M | 14.66M | 15.01M | 15.37M | 15.72M | 16.07M | 16.34M | 16.68M | 15.95M | 242.76K | 104.7K | 113.66K | 128.49K |
Goodwill & Intangibles | n/a | 38K | 92K | 155K | 219K | 148K | 182.97K | 222.05K | 263.37K | 185.91K | 222.1K | 275.45K | 328.8K | 244.03K | 164.09K | 197K | 227K | 263K |
Total Long-Term Assets | 35.34M | 35.73M | 36.23M | 36.83M | 37.2M | 38.44M | 34.43M | 33.32M | 34.06M | 23.85M | 23.89M | 24.53M | 21.25M | 21.01M | 4.07M | 2.03M | 2.13M | 794.17K |
Total Assets | 77.43M | 81.65M | 92.17M | 102.65M | 118.09M | 131.61M | 144.03M | 125.03M | 136.23M | 143.37M | 155.27M | 165.03M | 177.33M | 191.1M | 194.54M | 207.09M | 218M | 237.46M |
Account Payables | 3.95M | 1.95M | 3.19M | 2.71M | 4.72M | 3.6M | 3.7M | 1.22M | 3.76M | 1.83M | 1.95M | 1.03M | 4.62M | 2.26M | 7.13M | 3.14M | 909.52K | 3.15M |
Deferred Revenue | 718K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.43B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.38M | 1.36M | 1.34M | 1.31M | 1.29M | 1.27M | 1.25M | 1.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.03M | -1.36M | -1.34M | -1.31M | 1.87M | 1.24M | -1.25M | -1.22M | n/a | n/a | n/a | 1.98M | n/a | n/a | 3.91M | 3.23M | 7.07M | 12M |
Total Current Liabilities | 8.92M | 9.31M | 10.52M | 11.63M | 14.12M | 8.9M | 11.47M | 8.66M | 10.14M | 6.72M | 6.99M | 6.73M | 9.22M | 10.23M | 14.8M | 10.06M | 11.29M | 16.35M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 972K | 972K | 30M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 12.71M | 13.07M | 13.42M | 14.73M | 15.07M | 44.43M | 44.76M | 15.07M | 15.39M | 15.7M | 16M | 16.25M | 15.97M | 15.87M | 7.13M | n/a | n/a | n/a |
Total Liabilities | 21.64M | 22.38M | 23.94M | 26.36M | 29.19M | 53.33M | 56.23M | 23.74M | 25.53M | 22.42M | 22.99M | 22.98M | 25.18M | 26.1M | 14.8M | 10.06M | 11.29M | 16.35M |
Total Debt | 1.38M | 14.43M | 14.76M | 15.07M | 15.39M | 45.7M | 16M | 16.3M | 16.33M | 16.5M | 16.54M | 16.25M | 15.97M | 15.87M | n/a | n/a | n/a | n/a |
Common Stock | 71K | 71K | 71K | 71K | 71K | 71K | 70.69K | 70.68K | 70.6K | 70.49K | 70.47K | 70.47K | 70.41K | 70.37K | 70.36K | 68.02K | 67.83K | 67.79K |
Retained Earnings | -319.22M | -314.53M | -304.3M | -295.05M | -281.04M | -289.56M | -277.87M | -262.54M | -251.29M | -238.88M | -225.53M | -214.02M | -202.05M | -187.47M | -171.36M | -145.36M | -133.97M | -118.18M |
Comprehensive Income | -69K | -47K | -35K | 36K | -12K | -19K | 702.00 | -3.88K | 5.21K | 5.63K | -42.19K | -82.79K | -90.13K | 0.00 | n/a | -0.00 | n/a | -0.00 |
Shareholders Equity | 55.79M | 59.28M | 68.23M | 76.29M | 88.9M | 78.28M | 87.8M | 101.29M | 110.7M | 120.95M | 132.27M | 142.05M | 152.15M | 165M | 179.75M | 197.02M | 206.71M | 221.11M |
Total Investments | 30.84M | 42.77M | 47.75M | 68.82M | 68.33M | 83.44M | 98.35M | 45.76M | 41.36B | 60.65M | 89.76M | 85.55M | 81.78M | 2.78M | 1.63M | 1.63M | 1.61M | n/a |